ACTRN12617000586314尚未招募4 期
A Prospective, Randomized, Multicentre Study to Evaluate the Effect of Intravenous Iron Infusion Compared with Oral Iron Supplementation on the Quality of Life in Inflammatory Bowel Disease Patients with Non-Anaemic Hypoferritinaemia
Dr Stephen Inns0 个研究点目标入组 58 人开始时间: 2017年4月26日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 17 Years 至 80 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
1 期
Coronary Intervention Using the CardioMind Coronary Stent System for the treatment of stenotic lesions in small diameter native coronary arteriesCoronary artery diseaseCardiovascular - Coronary heart diseaseACTRN12607000578404CardioMind230
进行中（未招募）
不适用
A prospective, randomized, multicenter study to evaluate the impact of Darbepoetin alfa in combination with Ferric(III)-Carboxymaltose in comparison to Darbepoetin alfa and Ferric(III)-Carboxymaltose alone in patients with breast cancer and chemotherapy-induced anemia - CIA-StudyThis is a prospective, multicenter, randomized, comparative, parallel group, phase IV study to assess the efficacy and safety of FCM 800mg or Darbepoetin alfa 500µg or the combination of FCM 800mg and Darbepoetin alfa 500µg within 24h last chemotherapy administration in patients with breast cancer and chemotherapy induced anemia.EUCTR2011-001664-22-ATMedizinische Universität Wien - Universitätsklinik für Frauenheilkunde75
招募中
1 期
Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with AcromegalyMedDRA version: 20.0Level: PTClassification code 10000599Term: AcromegalySystem Organ Class: 10014698 - Endocrine disordersAcromegalyEUCTR2020-005431-70-BECrinetics Pharmaceuticals, Inc.52
招募中
3 期
A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with Acromegaly Treated with Long-acting Somatostatin Receptor Ligands.E220 Acromegaly and pituitary gigantismAcromegaly and pituitary gigantismE220PER-043-21Crinetics Pharmaceuticals, Inc.1
进行中（未招募）
1 期
Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects with AcromegalyAcromegalyEUCTR2020-005431-70-ATCrinetics Pharmaceuticals, Inc.52